resisttb
- Sep 3, 2020
- 1 min read

CHMP Grants Positive Opinion for Expanded Use of Otsuka’s Deltyba® (delamanid) in Children and Adole

Updated: Oct 4, 2020

The European Medicines Agency has updated its stance on Deltyba—with implications for children with DR-TB.

Read about it here.

1 view0 comments

Recent Posts

WHO TB Treatment Outcome Definitions

The World Health Organization (WHO) held an online consultation on the definitions of drug-resistant tuberculosis (DR-TB) treatment outcomes, on 17–19 November 2020. Read the full report here.

24-month follow-up confirms efficacy of NiX-TB regimen for XDR-TB

Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study

MDR-TB trial 6-month regimen appears effective

A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the r